InvestorsHub Logo
Followers 69
Posts 6662
Boards Moderated 0
Alias Born 02/10/2010

Re: JustGoDeep post# 166538

Friday, 01/04/2019 12:06:11 PM

Friday, January 04, 2019 12:06:11 PM

Post# of 333688
Yes Sir JGD, 472 million potential customers in the 5 added countries and Mundipharma has the resources to aggressively promote ActiPatch.

Mundi has the resources in both personnel and capital to promote its products. Mundi customers know and trust the 66 year old Mundipharma name which specializes in Pain Relief.

"Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries, employing over 8,600 people and generating annual revenues in excess of $3.4 billion."

"We are global leaders in pain medicine, with a significant and growing presence in our three other core therapeutic areas of respiratory, oncology and biosimilars."

"Pain is one of our core therapy areas and the Mundipharma network of independent associated companies in Europe has devoted over 35 years to learning about pain, understanding the mechanisms of pain and bringing new therapies for pain to the clinicians and patients who need them."

"Our heritage in helping to treat and manage pain gives us a truly unique perspective from which to help shape the future of pain management. Many patients have failed on current pain medicines, there are patients for whom no treatment exists and patients who could benefit from a novel treatment – it is on these patients where we focus our efforts."

"We have a broad portfolio of pain medicines and are always looking for what more can be done, what benefits can be realized in order to build an industry-leading pipeline to bring new pain medicines to the world that make a meaningful difference to patients."

Mundipharma AU created a new Product Category when they purchased the distribution rights to ActiPatch 6 months ago, 'Drug Free Pain Relief'.

https://www.mundipharma.com.au/drug-free-pain-relief/

https://www.mundipharma.com/about-mundipharma/

https://www.mundipharma.com/our-medicines/pain/


Philippines...………………...104 million

Malaysia …………………….31 million

Thailand ……………………..69 million

Indonesia...……………….…263 million

Singapore...……………………5.6 million